Mentaily News
3 articles
growth-positive
Israeli companies AccuBeat, Mentaily Innovations, Newton Tech, and Tuned will partner with U.S. counterparts on projects spanning quantum hardware, mental health, and rehabilitation, as part of the new grants approved by the foundation.
Israeli companies, including AccuBeat, Mentaily Innovations, Newton Tech, and Tuned, have partnered with U.S. counterparts on projects in quantum hardware, mental health, and rehabilitation. The Israel-U.S. Binational Industrial Research and Development (BIRD) Foundation has approved $5.5 million in grants to support these collaborations, which span innovations in hardware, medical devices, mental health, and rehabilitation. The projects will leverage private-sector funding, resulting in a combined investment of $14 million. The BIRD Foundation facilitates collaboration between U.S. and Israeli companies through conditional grants, covering activities from R&D to early sales and marketing stages. The grants were approved during the BIRD Foundations Board of Governors meeting on September 16, 2025.
PartnersInvestment
growth-positive
Mentaily raises $3 million Seed round to tackle global mental health crisis with AI-powered platform | CTech
Mentaily, an Israeli startup founded in 2024, has raised $3 million in a Seed funding round to advance its AI-powered mental health platform, LIV. The funding was led by a US-based family office and included contributions from Israeli family offices and impact funds. LIV, designed to simulate clinical psychiatric sessions, aims to address the global shortage of mental health professionals by providing scalable and personalized mental health assessments. The platform is already in use across various institutions in Israel and is being developed in collaboration with the ARC Innovation Center, Sheba Medical Center, Microsoft, and KPMG. The new funding will help Mentaily expand its services both locally and internationally, focusing on high-stress populations like military personnel.
InvestmentPartnersProduct Stage
growth-positive
Can we talk? LIV’s GenAI gets trauma sufferers to open up | CTech
The article discusses the development and deployment of LIV, a generative AI-based platform designed to streamline mental healthcare, developed by Sheba Medical Center, ARC, Microsoft, and KPMG. LIV aims to alleviate the mental health crisis in Israel, exacerbated by recent events, by improving the efficiency of mental health practitioners. The platform offers personalized patient interactions and diagnostics, significantly reducing the time to treatment. LIV is not intended to replace human therapists but to support them in making preliminary clinical diagnoses. The platform is currently available in Hebrew and English, with plans to expand to other languages. LIV will become the first commercial product of Mentaily, a new startup emerging from Shebas ARC incubator.
PartnersProduct Stage
